AtrimusRX AB

ABActive

Org 5590660725Hammarbacken 6 A, 191 49 SollentunaWholesale of pharmaceutical and medical goods · NACE 4646Est. 201611 employees

Overview Financials People & ownership Related companies

AtrimusRX AB is a Swedish AB based in Sollentuna, operating in the Partihandel med medicinsk utrustning och apoteksvaror sector. Incorporated in 2016, the company has 11 employees and reported revenue of SEK 154,4M in its latest annual filing.

Revenue 2024

SEK 154,4M

-48% vs 2023

EBITDA margin

15.4%

-56% vs 2023

Equity ratio

65.3%

Financial strength

Net profit 2024

SEK 15,5M

-62% vs 2023

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 154,4M	-48%
EBITDA	SEK 23,8M	-56%
Net profit	SEK 15,5M	-62%
Total assets	SEK 65,5M	-38%
Equity	SEK 42,8M	-9%
Employees	11	—

Contact

Address

Hammarbacken 6 A, 191 49 Sollentuna

nicky.nadem@hotmail.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of AtrimusRX AB?

AtrimusRX AB is registered with Bolagsverket / SCB under Org 5590660725.

What is the revenue of AtrimusRX AB?

AtrimusRX AB reported revenue of SEK 154,4M in 2024.

How many employees does AtrimusRX AB have?

AtrimusRX AB employs 11 people as of the latest annual report.

Who is the CEO of AtrimusRX AB?

Frank Dagfinn Björsbo is Chief Auditor of AtrimusRX AB, in role since 2020.

Who is the chairman of AtrimusRX AB?

Fariba Seyed Mozaffari chairs the board of AtrimusRX AB, in role since 2021.

Where is AtrimusRX AB headquartered?

AtrimusRX AB's registered address is Hammarbacken 6 A 5tr.

AtrimusRX AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on AtrimusRX AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on AtrimusRX AB